Recent Quotes

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		-0.050		-0.040		0.0100
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
LPCN	Lipocine	1.41	0.05	3.68%		120.1M

Lipocine Frequently Asked Questions

How do I buy Lipocine (LPCN) stock?

You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.

View our list of the best stock brokerages.

Who are Lipocine's (LPCN) competitors?

Other companies in Lipocine’s space includes: Graybug Vision (NASDAQ:GRAY), Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX), Cocrystal Pharma (NASDAQ:COCP) and Onconova Therapeutics (NASDAQ:ONTX).

What is the target price for Lipocine (LPCN) stock?

The latest price target for Lipocine (NASDAQ: LPCN) was reported by Cantor Fitzgerald on June 24, 2021. The analyst firm set a price target for 3.00 expecting LPCN to rise to within 12 months (a possible 120.59% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Lipocine (LPCN)?

The stock price for Lipocine (NASDAQ: LPCN) is $1.36 last updated Wed Jun 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Lipocine (LPCN) pay a dividend?

There are no upcoming dividends for Lipocine.

When is Lipocine (NASDAQ:LPCN) reporting earnings?

Lipocine’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is Lipocine (LPCN) going to split?

There is no upcoming split for Lipocine.

What sector and industry does Lipocine (LPCN) operate in?

Lipocine is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.